Zota Health Care Limited (NSE:ZOTA)
1,549.30
-17.30 (-1.10%)
At close: Dec 19, 2025
Zota Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 4,019 | 2,930 | 1,805 | 1,400 | 1,312 | 1,068 | Upgrade |
Other Revenue | -0 | - | - | 7.94 | 0.77 | 3.98 | Upgrade |
| 4,019 | 2,930 | 1,805 | 1,408 | 1,313 | 1,072 | Upgrade | |
Revenue Growth (YoY) | 82.58% | 62.32% | 28.23% | 7.22% | 22.47% | 12.62% | Upgrade |
Cost of Revenue | 1,785 | 1,385 | 971.65 | 835.11 | 867.29 | 733.65 | Upgrade |
Gross Profit | 2,235 | 1,545 | 833.24 | 572.41 | 445.41 | 338.21 | Upgrade |
Selling, General & Admin | 1,349 | 998.59 | 371.74 | 212.65 | 159.4 | 216.07 | Upgrade |
Other Operating Expenses | 808.78 | 593.72 | 385.95 | 278.46 | 137.26 | 111.75 | Upgrade |
Operating Expenses | 2,746 | 2,024 | 958.55 | 610.68 | 333.37 | 359.5 | Upgrade |
Operating Income | -511.77 | -479.32 | -125.31 | -38.27 | 112.05 | -21.29 | Upgrade |
Interest Expense | -102.9 | -89.74 | -41.99 | -24.86 | -2.58 | -0.5 | Upgrade |
Interest & Investment Income | 17.09 | 17.09 | 9.37 | 8.82 | 13.16 | 7.2 | Upgrade |
Currency Exchange Gain (Loss) | 2.56 | 2.56 | 1.94 | 2.37 | 2.3 | 1.15 | Upgrade |
Other Non Operating Income (Expenses) | 2.46 | -17.06 | -5.64 | -0.36 | -0.58 | -0.5 | Upgrade |
EBT Excluding Unusual Items | -592.56 | -566.48 | -161.63 | -52.29 | 124.35 | -13.94 | Upgrade |
Merger & Restructuring Charges | -7.81 | -7.81 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.08 | -0.08 | - | - | - | - | Upgrade |
Other Unusual Items | -2.07 | -2.07 | - | 5.38 | - | 10.29 | Upgrade |
Pretax Income | -602.53 | -576.44 | -161.63 | -46.91 | 124.35 | -3.65 | Upgrade |
Income Tax Expense | 15.53 | -9.06 | -18.15 | 10.82 | 35.27 | -1.57 | Upgrade |
Earnings From Continuing Operations | -618.06 | -567.39 | -143.48 | -57.73 | 89.08 | -2.09 | Upgrade |
Minority Interest in Earnings | -0.31 | 3.41 | - | - | - | - | Upgrade |
Net Income | -618.37 | -563.98 | -143.48 | -57.73 | 89.08 | -2.09 | Upgrade |
Net Income to Common | -618.37 | -563.98 | -143.48 | -57.73 | 89.08 | -2.09 | Upgrade |
Shares Outstanding (Basic) | 29 | 27 | 26 | 25 | 25 | 25 | Upgrade |
Shares Outstanding (Diluted) | 29 | 27 | 26 | 25 | 25 | 25 | Upgrade |
Shares Change (YoY) | 10.35% | 6.33% | 1.93% | 1.11% | 1.32% | - | Upgrade |
EPS (Basic) | -21.37 | -20.68 | -5.59 | -2.29 | 3.58 | -0.09 | Upgrade |
EPS (Diluted) | -21.37 | -20.68 | -5.59 | -2.29 | 3.58 | -0.09 | Upgrade |
Free Cash Flow | -1,251 | -959.42 | -226.94 | -145.05 | 100.84 | -28.18 | Upgrade |
Free Cash Flow Per Share | -43.25 | -35.18 | -8.85 | -5.76 | 4.05 | -1.15 | Upgrade |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 1.500 | 1.000 | Upgrade |
Dividend Growth | - | - | - | -33.33% | 50.00% | - | Upgrade |
Gross Margin | 55.60% | 52.73% | 46.17% | 40.67% | 33.93% | 31.55% | Upgrade |
Operating Margin | -12.73% | -16.36% | -6.94% | -2.72% | 8.54% | -1.99% | Upgrade |
Profit Margin | -15.38% | -19.25% | -7.95% | -4.10% | 6.79% | -0.19% | Upgrade |
Free Cash Flow Margin | -31.13% | -32.75% | -12.57% | -10.31% | 7.68% | -2.63% | Upgrade |
EBITDA | -212.12 | -336.18 | -63.1 | 2.83 | 140.75 | 9.61 | Upgrade |
EBITDA Margin | -5.28% | -11.47% | -3.50% | 0.20% | 10.72% | 0.90% | Upgrade |
D&A For EBITDA | 299.65 | 143.15 | 62.21 | 41.1 | 28.7 | 30.9 | Upgrade |
EBIT | -511.77 | -479.32 | -125.31 | -38.27 | 112.05 | -21.29 | Upgrade |
EBIT Margin | -12.73% | -16.36% | -6.94% | -2.72% | 8.54% | -1.99% | Upgrade |
Effective Tax Rate | - | - | - | - | 28.37% | - | Upgrade |
Revenue as Reported | 4,059 | 2,950 | 1,816 | 1,419 | 1,328 | 1,080 | Upgrade |
Advertising Expenses | - | 121.52 | 62.27 | 78.95 | 50.1 | 115.31 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.